What is the market doing?
What the tape says about GLUE
Monte Rosa Therapeutics, Inc. is +213% over the past year while the S&P 500 is +20%: 193 points ahead of the market.
+213%
1-year return · S&P 500 +20%
- vs 200-day average
- −20%
vs 200-day average · a clear downtrend
- RSI (14)
- 43
RSI (14) · neutral
- Below its 52-week high
- 44%
Below its 52-week high
Details›
- Last close2026-09-08
- $14.28
- 1 monthS&P 500 −0.30%
- −9.2%
- 1 yearS&P 500 +20%
- +213%
- 5 yearsS&P 500 +85%
- −57%
- vs 50-day average$17.95
- −20%
- 52-week high
- $25.31
- 52-week low
- $4.40
- Annualised volatility
- 111%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
- −$1.7M
| Year | Return |
|---|---|
| 2026 (year to date) | −8.9% |
| 2025 | +126% |
| 2024 | +23% |
| 2023 | −26% |
| 2022 | −63% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | −4.0% |
| Feb | 5 | 2 of 5 | −3.2% |
| Mar | 5 | 2 of 5 | +2.9% |
| Apr | 5 | 2 of 5 | −13% |
| May | 5 | 2 of 5 | −0.19% |
| Jun | 5 | 3 of 5 | +5.3% |
| Jul | 6 | 5 of 6 | +6.2% |
| Aug | 6 | 2 of 6 | +2.1% |
| Sep | 6 | 3 of 6 | −1.7% |
| Oct | 5 | 4 of 5 | +25% |
| Nov | 5 | 2 of 5 | +2.8% |
| Dec | 5 | 2 of 5 | +8.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.